TY  - GEN
AU  - Davis,Ian D
AU  - Brady,Ben
AU  - Kefford,Richard F
AU  - Millward,Michael
AU  - Cebon,Jonathan
AU  - Skrumsager,Birte K
AU  - Mouritzen,Ulrik
AU  - Hansen,Lasse Tengbjerg
AU  - Skak,Kresten
AU  - Lundsgaard,Dorthe
AU  - Frederiksen,Klaus Stensgaard
AU  - Kristjansen,Paul E G
AU  - McArthur,Grant
TI  - Clinical and biological efficacy of recombinant human interleukin-21 in patients with stage IV malignant melanoma without prior treatment: a phase IIa trial
SN  - 1078-0432
PY  - 2009///0416
KW  - Adult
KW  - Aged
KW  - Female
KW  - Humans
KW  - Interleukin-2 Receptor alpha Subunit
KW  - blood
KW  - Interleukins
KW  - adverse effects
KW  - Male
KW  - Melanoma
KW  - drug therapy
KW  - Middle Aged
KW  - Neoplasm Staging
KW  - Recombinant Proteins
KW  - therapeutic use
KW  - T-Lymphocyte Subsets
KW  - immunology
KW  - Interleukin-21
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1158/1078-0432.CCR-08-2663
ER  -